Improved sexual function with testosterone replacement therapy in hypogonadal men: Real-world data from the Testim Registry in the United States (TRiUS)

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3204-3213

  Khera, Mohit ^a   Bhattacharya, Rajib K ^b   Blick, Gary ^c   Kushner, Harvey ^d   Nguyen, Dat ^d   Miner, Martin M ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c Circle Medical LLC ^*  (United States)

^d Auxilium Pharmaceuticals   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Brief Male Sexual Function Inventory (BMSFI); Erectile dysfunction (ED); Hypogonadism; PDE5 inhibitors; Testim; Testosterone deficiency; Testosterone gel; Testosterone Replacement Therapy (TRT); TRiUS Registry

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ANDROGEN THERAPY; ANTHROPOMETRY; ARTICLE; BRIEF MALE SEXUAL FUNCTION INVENTORY; COHORT ANALYSIS; DISEASE REGISTRY; EJACULATION; FOLLOW UP; FUNCTIONAL ASSESSMENT INVENTORY; HUMAN; HYPOGONADISM; INFORMATION PROCESSING; LIBIDO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PENIS ERECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEXUAL FUNCTION; UNITED STATES;

EID: 80255138857     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02436.x     Document Type: Article

References (29)

1. Wessells H, Joyce GF, Wise M, Wilt TJ. Erectile dysfunction. J Urol 2007;177:1675-81.
2. Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ, Ansari MT, Garritty C, Soares-Weiser K, Daniel R, Sampson M, Fox S, Moher D, Wilt TJ. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis. Ann Intern Med 2009;151:650-61.
3. Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED, Jr, Rellini AH, Segraves T. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010;7:1598-607.
4. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007;120:151-7.
5. Rizvi SJ, Kennedy SH, Ravindran LN, Giacobbe P, Eisfeld BS, Mancini D, McIntyre RS. The relationship between testosterone and sexual function in depressed and healthy men. J Sex Med 2009;7(2 pt 1):816-25.
6. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med 2007;357:2472-81.
7. Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R. Erectile dysfunction and testosterone deficiency. Front Horm Res 2009;37:108-22.
8. Gore J, Rajfer J. The role of serum testosterone testing: Routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction. Rev Urol 2004;6:207-10.
9. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, Buvat J. The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract 2006;60:1087-92.
10. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M. Endocrine aspects of male sexual dysfunctions. J Sex Med 2010;7:1627-56.
11. Lazarou S, Morgentaler A. Hypogonadism in the man with erectile dysfunction: What to look for and when to treat. Curr Urol Rep 2005;6:476-81.
12. Seftel AD, Mack RJ, Secrest AR, Smith TM. Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning. J Andol 2004;25:963-72.
13. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 2003;88:2673-81.
14. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91:69-74.
15. ® 1% testosterone gel in hypogonadal men. Rev Urol 2005;7:87-94.
16. Miner MM, Khera M, Bhattacharya R, Blick G, Kushner H. Baseline data from the TRiUS registry: Symptoms and comorbidities of testosterone deficiency. Postgrad Med 2011;123:17-27.
17. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ. A brief male sexual function inventory for urology. Urology 1995;46:697-706.
18. Mykletun A, Dahl AA, O'Leary MP, Fossa SD. Assessment of male sexual function by the Brief Sexual Function Inventory. BJU Int 2006;97:316-23.
19. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000;85:2839-53.
20. Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Clin Endocrinol 1997;47:727-37.
21. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-98.
22. Arver S, Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol 1996;155:1604-8.
23. Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med 2010;7:2572-82.
24. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008;179:S97-S102.
25. Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res 2008;20:213-7.
26. Steidle C, Witt MA, Matrisciano J, Block JE. Sexual functioning and satisfaction in nonresponders to testosterone gel: Potential effectiveness of retreatment in hypogonadal males. Clin Cornerstone 2005;7(suppl 4):S20-5.
27. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf) 2003;58:632-8.
28. Traish A, Kim N. The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function. J Sex Med 2005;2:759-70.
29. Chiang HS, Cho SL, Lin YC, Hwang TI. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score. Urology 2009;73:762-6.